Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DEXTENZA VS. PREDNISOLONE ACETATE 1% in the Incidence of Pseudophakic Macular Edema in Patients With Diabetic Retinopathy Undergoing Cataract Surgery

NCT04362241 is registered in ClinicalTrials.gov with Ophthalmic Consultants of the Capital Region as lead sponsor.

NCT NCT04362241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04362241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DEXTENZA VS. PREDNISOLONE ACETATE 1% in the Incidence of Pseudophakic Macular Edema in Patients With Diabetic Retinopathy Undergoing Cataract Surgery
Lead sponsor
Ophthalmic Consultants of the Capital Region
Phase
Phase 4
Overall status
Unknown status
Start date
August 7, 2020
Completion date
March 31, 2022
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

retinopathy, diabetic